Office: 344 Harriman Hall
Email: jiaru.bai AT stonybrook.edu
Education:
Ph.D. in Operations and Decision Technologies, University of California, Irvine, 2017.
M.S. in Statistics, University of California, Irvine, 2014.
B.S. in Economics, Beijing University, 2012.
B.S. in Engineering, Beihang University, 2012.
All That Glitters Is Not Gold: The Impact of Certification Test Costs in Online Labor Markets
Jiaru Bai, Qiang Gao, Paulo Goes, Mingfeng Lin
Forthcoming at Information Systems Research. (UTD 24, FT 50, ABDC A*) LINK
Modeling Cost-effectiveness Analysis of Treatment Sequencing
Cristina del Campo, Jiaru Bai, L Robin Keller
Socio-Economic Planning Sciences, 2025 Jun, 99:102210. LINK
Concealing Borrowers’ Failure History in Online P2P Lending: A Natural Experiment
Jiaru Bai, Qiang Gao
Decision Sciences. 2024 Aug, 55(4): 398-413. (ABDC A*) LINK
Hiding in Plain Sight: Surge Pricing and Strategic Providers
Jiaru Bai, Hans Sebastian (Seb) Heese, Manish Tripathy
Production and Operations Management, 2023 Dec;32(12):3837-55. (UTD 24, FT 50, ABDC A*) LINK
Driver Collusion in Ride-hailing Platforms
Manish Tripathy, Jiaru Bai, Hans Sebastian (Seb) Heese
Decision Sciences. 2023 Aug, 54(4): 434-446. (ABDC A*) LINK
Finalist, Best Paper Award in Decision Sciences, 2024
Top 10% of the Most Downloaded Papers Published in Decision Sciences for Papers Published in 2022
Can Two Competing On-demand Service Platforms be Profitable?
Jiaru Bai, Christopher S. Tang
International Journal of Production Economics, 2022 Oct; 250:108672. (ABDC A) LINK
Special Issue Celebrating Volume 250 of the International Journal of Production Economics
Optimal Subsidy Schemes and Budget Allocations for Government-Subsidized Trade-in Programs
Jiaru Bai, Shu Hu, Luyi Gui, Kut C. So, Zujun Ma
Production and Operations Management, 2021, 30(8):2689-706. (UTD 24, FT 50, ABDC A*) LINK
Retail Distribution Strategy with Outlet Stores
Jiaru Bai, Haresh Gurnani, Shuya Yin
Production and Operations Management, 2022, 31(1):281-303. (UTD 24, FT 50, ABDC A*) LINK
Coordinating Supply and Demand on an On-demand Service Platform with Impatient Customers
Jiaru Bai, Kut C. So, Christopher S. Tang, Xiqun (Michael) Chen, Hai Wang
Manufacturing & Service Operations Management, 2019, 21(3): 556-570. (UTD 24, FT 50, ABDC A*) LINK
MSOM Blog: Demand-Based Payout Ratio for Coordinating Supply and Demand on an On-Demand Ride Sharing Platform.
UCLA Anderson Review: Uber-Like Services: Variable Driver-Company Revenue Split Improves Profit.
Binghamton University SOM Magazine: Be ``Dynamic".
2017 POMS Supply Chain Management College Student Paper Competition First Prize.
Cost-effectiveness of maintenance therapy in advanced ovarian cancer: Paclitaxel, bevacizumab, niraparib, rucaparib, olaparib, and pembrolizumab.
Juliet E. Wolford, Jiaru Bai, Lindsey E. Minion, Robin Keller, et al.
Journal of Clinical Oncology 36, no. 15_suppl (May 20, 2018) 5508-5508. LINK
2018 Best of ASCO projects
2018 Conquer Cancer Foundation of ASCO/Sherwin Family Endowed Merit Award
Evaluating the cost-effectiveness of current FDA-approved PARP inhibitors for the treatment of recurrent ovarian cancer
Juliet E. Wolford, Jiaru Bai, Ramez H. Eskander, Robin L. Keller, et al.
Journal of Clinical Oncology 35, no. 15_suppl (May 2017) 5516-5516. LINK
Cancer Network: PARP Inhibitors Effective but Costly for Recurrent Ovarian Cancer.
Top 15 most accessed articles of 2017 (Society of Gynecology Oncology).
A queueing model for managing small projects under uncertainties
Jiaru Bai, Kut C. So, Christopher S. Tang
European Journal of Operational Research, 2016, 253(3): 777-790. (ABDC A*) LINK
Cost-effectiveness of niraparib, rucaparib, and olaparib for treatment of platinum-resistant, recurrent ovarian carcinoma
Juliet E. Wolford, Jiaru Bai, Kathleen N. Moore, et al.
Gynecologic Oncology, 2020, 157(2), 500-507. LINK
Comparing Markov and non-Markov alternatives for cost-effectiveness analysis: Insights from a cervical cancer case
Cristina del Campo, Jiaru Bai, L Robin Keller
Operations Research for Health Care, 2019, 21, 32-43. LINK
SOLO1 versus SOLO2: Cost-effectiveness of olaparib as maintenance therapy for newly diagnosed and platinum-sensitive recurrent ovarian carcinoma among women with germline BRCA mutations (gBRCAmut).
Juliet E. Wolford, Krishnansu Sujata Tewari, Su-Ying Liang, Jiaru Bai, et al.
Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019) 5545-5545. LINK
Time-based payout ratio for coordinating supply and demand on an on-demand service platform
Jiaru Bai, Kut C. So, Christopher S. Tang, Xiqun (Michael) Chen, Hai Wang
Sharing Economy: Making Supply Meet Demand. 2019:115-36. LINK
Evaluating the cost-effectiveness of current FDA-approved PARP inhibitors for the treatment of recurrent ovarian cancer
Juliet E. Wolford, Jiaru Bai, Ramez Hassef Eskander, Robin Keller, et al.
Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017) 5516-5516. LINK
Markov chain models in practice: A review of low cost software options.
Jiaru Bai, Cristina del Campo, Robin Keller
Investigación Operacional 38, no.1(2017). LINK
Lindsey Minion, John K. Chan, Bradley J. Monk, and Krishnansu Sujata Tewari. "A Markov model to evaluate cost-effectiveness of the PARP inhibitor, olaparib, for fourth-line treatment of recurrent ovarian cancer." (2016): 5563-5563.
Juliet E. Wolford, Jiaru Bai, Ramez Hassef Eskander, Robin Keller, et al.
Journal of Clinical Oncology 34, no. 15_suppl (May 20, 2016) 5563-5563. LINK
A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer
Lindsey E. Minion, Jiaru Bai, Bradley J. Monk, Robin L. Keller, et al.
Gynecologic Oncology, 2015, 137(3): 490-496. LINK
2025, Principal Investigator, OVPR Seed Grant, Stony Brook University ($55,000)
2024, Finalist, Best Paper Award, Decision Sciences
2024, Dean's Emerging Scholar Award for Research, Stony Brook University, SUNY ($500)
2024, Principal Investigator, IBM Center for the Business of Government Research Report Stipends Award ($20,000)
2024, Top 10% of the Most Downloaded Papers Published in Decision Sciences for Works Published in 2022, Wiley
UUP Individual Development Award, 2023-2024 ($2,000)
2021-2022, Robinson-Lightcap Faculty Fellowship, Wake Forest University ($2,500 Research Fund / Year)
2018, Best of ASCO Projects
2018, Conquer Cancer Foundation of ASCO/Sherwin Family Endowed Merit Award based on the project "Cost-effectiveness of maintenance therapy in advanced ovarian cancer: Paclitaxel, bevacizumab, niraparib, rucaparib, olaparib, and pembrolizumab"
2017, Top 15 Most Accessed Articles of 2017 by the Society of Gynecology Oncology
2017, Dean’s Honor Roll for Excellence in Teaching, Binghamton University, SUNY
2017, First Prize, Supply Chain Management College Student Paper Competition, POMS
2016, Ray Watson Fellowship, UC Irvine ($520)